TP53 and cancer: Taken together, our chemical probe MB725 displays selective targeting of Y220C cancer cells, and the correlation between in vitro thermal stabilization and selective viability reduction in Y220C cell lines represents an important milestone towards first-in-class anticancer drugs that rescue p53-Y220C function.